Smokers should be warned of the risks

Article

A study published online ahead of print in Ophthalmology, has highlighted the associated risks between blindness and smoking and warns that people with unilateral age-related macular degeneration (AMD) and age-related maculopathy (ARM) should be advised that they are increasing their risk of developing the disease in the second-eye.

A study published online ahead of print in Ophthalmology, has highlighted the associated risks between blindness and smoking and warns that people with unilateral age-related macular degeneration (AMD) and age-related maculopathy (ARM) should be advised that they are increasing their risk of developing the disease in the second-eye.

Usha Chakravathy and colleagues from Queen's University of Belfast, UK, randomly sampled 4750 patients (>/= 65 years) from seven study centres across Europe (Norway, Estonia, UK, France, Italy, Greece and Spain). Smoking history was ascertained by a structured questionnaire. Multinomial and binary logistic regressions were used to examine the association between smoking history and ARM grade and type of AMD.

Each participant underwent a full eye examination and digital retinal photography and the resulting images were graded at a single centre. Images were graded according to the International Classification System for ARM and stratified using the Rotterdam staging system into five stages (ARM 0-3 and ARM 4, also known as AMD). AMD was then classified as either neovascular AMD or geographic atrophy (GA).

A total of 158 cases were classified as AMD (109 neovascular AMD, 49 GA) and 2260 demonstrated no signs of ARM. Current smokers had increased odds of neovascular AMD (odds ratio [OR], 2.6; 95% confidence interval [CI], 1.4-4.8) or GA (OR, 4.8; 95% CI, 2.1-11.1), whereas for ex-smokers the odds were around 1.7. Compared to those with unilateral AMD, those with bilateral AMD were more likely to have a history of heavy smoking in the previous 25 years. There was no consistent association with ARM grades 1 to 3 and smoking.

The authors of this study believe that their findings highlight the need for increased public awareness of the risks associated with smoking and the benefits of quitting smoking.

Recent Videos
3 experts are featured in this series.
3 experts are featured in this series.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.